Skip to main content

Venture Funding and the NIH SBIR Program (2009) / Chapter Skim
Currently Skimming:

Appendix A: Venture-funded Firms Among the 200 Most Prolific Winners of NIH Phase II Awards 1992-2002
Pages 71-75

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 71...
... Appendix A Venture-funded Firms Among the 200 Most Prolific Winners of NIH Phase II Awards 1992-2002 71
Read the entire page →
From page 72...
... 2/1/1999 7/1/2000 5 Immusol, Inc. 9/30/1996 9/1/1999 4 Inotek Pharmaceuticals Corporation 3/1/1998 8/1/2001 14 Invitrogen Corporation 9/1/1995 9/30/1998 4 Isis Pharmaceuticals 9/1/1991 3/1/1999 4 Martek Biosciences Corporation 9/30/1991 9/30/1995 3 Medical Physics Colorado 5/1/1990 2/15/1992 4 Medimmune, Inc.
Read the entire page →
From page 73...
... 73 APPENDIX A All Awards VC Funding Total SBIR Most Recent Number of Funding 1st Round Round Rounds Total VC Funding 4,905,444 8/18/1989 10/30/2002 8 36,385,000 8,924,132 12/1/1984 12/1/1984 1 3,000,000 8,566,387 5/1/2003 5/1/2003 1 10,500,000 6,967,861 10/1/1987 10/1/1987 1 150,000 2,267,025 1/1/1986 6/21/1997 9 35,879,000 2,647,188 1/11/1996 11/30/2000 5 47,350,000 3,989,316 12/1/1992 11/2/2001 7 26,561,000 2,904,807 9/1/1987 3/27/2002 6 45,700,000 7,971,063 12/2/1994 10/2/1997 3 59,330,000 3,793,553 1/9/1987 11/23/1992 4 51,000,000 4,758,137 9/1/1992 9/23/1998 5 36,283,000 4,026,867 8/1/1987 11/22/1991 4 68,000,000 4,228,546 12/1/1994 2/14/2000 5 210,200,000 3,350,438 10/1/1996 8/30/2001 5 42,900,000 3,262,764 1/15/1986 6/20/2003 8 32,440,000 3,238,220 3/1/1986 7/1/1993 13 29,980,000 4,352,150 3/1/1988 3/1/1988 1 900,000 11,827,620 1/1/1980 1/1/1980 1 750,000 3,581,611 4/1/1998 5/22/2000 7 73,522,000 1,748,679 12/3/1988 4/1/1995 9 40,100,000 3,342,616 7/1/1988 6/1/1995 7 32,596,000 9,643,061 6/7/2002 6/6/2003 2 7,300,000 2,441,576 5/1/1986 2/1/1990 4 43,870,000 5,715,123 11/30/1998 11/1/1999 2 36,567,000 3,347,984 6/1/2001 9/24/2003 2 23,500,000 29,421,600 3/31/2004 3/31/2004 1 20,000,000 4,254,170 6/20/1997 6/20/1997 1 15,000,000 3,210,263 2/1/1989 8/11/1994 6 17,490,000 3,220,694 1/15/1986 11/23/1993 5 22,750,000 2,698,149 12/30/1991 12/30/1991 1 20,000 2,912,945 5/1/1988 12/9/1991 5 143,850,000 1,746,413 5/1/1983 10/1/1993 4 3,557,000 4,264,334 5/1/1981 7/1/1987 15 76,598,000 10,349,174 9/25/1992 5/23/1996 12 43,000,000 3,147,990 7/1/1986 3/1/1987 2 5,598,000 8,563,722 3/1/1988 3/1/1988 1 4,000,000 7,889,307 9/1/1983 9/1/1983 1 750,000 9,782,753 8/1/1987 8/1/1990 4 3,337,000 8,175,374 5/9/1995 7/1/1995 2 492,000 14,190,507 1/1/1995 12/1/1995 1 5,670,000 3,727,127 1/1/1990 2/1/1997 14 43,577,000 2,704,476 6/1/1982 6/1/1982 1 5,425,000 3,334,165 7/1/1997 7/1/1997 1 435,000 7,514,150 11/1/1979 1/1/1987 3 3,750,000 8,231,063 9/1/1983 1/1/1986 2 3,400,000 continued
Read the entire page →
From page 74...
... 4/1/1996 8/1/1999 3 Valentis 3/26/1993 3/1/1997 4 Volumetrics Medical Imaging 8/1/1993 6/1/2000 3 Total 285 Legend 34 First VC funding before first SBIR Phase II 17 Last VC funding after start of latest SBIR Phase II 6 First VC funding after last start date for SBIR Phase II 51 Total VC-funded companies identified as NIH SBIR Top 200 SOURCE: Award data: National Institutes of Health data delivered to the National Research Council; VC data: Thomson Financial, VentureSource, and RDNA databases.
Read the entire page →
From page 75...
... 7 APPENDIX A All Awards VC Funding Total SBIR Most Recent Number of Funding 1st Round Round Rounds Total VC Funding 4,754,214 4/1/1987 12/31/1992 2 1,873,000 7,068,657 1/1/2001 4/1/2001 2 28,673,000 3,778,257 6/30/1995 7/26/2000 5 78,064,000 3,384,761 2/5/2002 2/5/2002 1 12,075,000 3,350,068 8/12/1993 10/1/2002 6 47,405,000 2,432,255 1/1/1995 6/27/2003 6 10,706,000 272,332,457 224 1,592,258,000
Read the entire page →

Key Terms

  • pharmaceuticals corporation
  • health data
  • invitrogen corporation
  • imaging corporation
  • martek biosciences

  • biomedical development
  • development corporation
  • photon imaging
  • cambridge neuroscience
  • companies identified

  • nih sbir
  • medical physics
  • physics colorado
  • inotek pharmaceuticals
  • volumetrics medical

  • thomson financial
  • corixa corporation
  • medical imaging
  • genaissance pharmaceuticals
  • start date

  • foster miller
  • data delivered
  • isis pharmaceuticals
  • biosciences corporation
  • physical optics

  • cortechs labs
  • rdna databases
  • idec pharmaceuticals
  • optics corporation
  • sbir top


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.